GM-CSF-surface-modified B16.F10 melanoma cell vaccine

Vaccine

Volumn 24, Issue 25, 2006, Pages 5265-5268

  Gao, Jimin ^a   Huang, Shuqi ^a   Li, Ming ^a   Luo, Rongcheng ^a   Wang, Xiaoning ^a   Takashima, Akira ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biotinylation; GM CSF; Streptavidin; Surface modification; Whole tumor cell vaccination

Indexed keywords

BIOTIN DERIVATIVE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; STREPTAVIDIN; STREPTAVIDIN TAGGED GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR CELL VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTINYLATION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DRUG ACTIVITY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY; VACCINATION; WILD TYPE;

ANIMALS; BIOTINYLATION; CANCER VACCINES; CELL LINE, TUMOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; STREPTAVIDIN; VACCINATION;

EID: 33744540495     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.031     Document Type: Article

References (6)

1. Sano T., and Cantor C.R. Streptavidin-containing chimeric proteins: design and production. Methods Enzymol 326 (2000) 305-311
2. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 90 (1993) 3539-3543
3. Gillies S.D., Lan Y., Brunkhorst B., Wong W.K., Li Y., and Lo K.M. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer. Cancer Immunol Immunother 51 (2002) 449-460
4. Yei S., Bartholomew R.M., Pezzoli P., Gutierrez A., Gouveia E., Bassett D., et al. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16.F10 melanoma cell vaccine. Gene Ther 9 (2002) 1302-1311
5. Soo Hoo W., Lundeen K.A., Kohrumel J.R., Pham N.L., Brostoff S.W., Bartholomew R.M., et al. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model. J Immunol 162 (1999) 7343-7349
6. Paganelli G., Grana C., Chinol M., Cremonesi M., De Cicco C., De Braud F., et al. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med 26 (1999) 348-357